Statistics Leader​/Associate Director Oncology Statistics

Job description

Site Name: UK London New Oxford Street, Stevenage, USA - Pennsylvania - Upper Providence

Posted Date: Feb 10 2026

We create a place where people can grow, be their best, be safe, and feel welcome, valued and included. We offer a competitive salary, an annual bonus based on company performance, healthcare and wellbeing programmes, pension plan membership, and shares and savings programme.

We embrace modern work practises; our Performance with Choice programme offers a hybrid working model, empowering you to find the optimal balance between remote and in-office work.

Discover more about our company wide benefits and life at GSK on our webpage Life at GSK.

You will lead statistical planning and delivery across clinical programs and contribute to clinical developments plans within oncology. You will work closely with clinical, regulatory, safety, data science and commercial teams. You will design robust clinical trials and analyses that shape development decisions and regulatory strategy. You will drive methodological innovation and mentor colleagues. Join us to grow your career, make a real impact on patient-focused R&D, and help unite science, technology and talent to get ahead of disease together.

• Provide statistical support to Projects across Oncology pipeline
• Lead statistical design, analysis and interpretation for clinical programs across development phases using a wide range of statistical approaches (e.g. Bayesian methodology)
• Use simulations and advanced statistical methodology to inform trial design and risk assessment.
• Review and contribute to statistical analysis plans, protocols and regulatory submissions.
• Work with cross-functional teams to translate statistical insight into program strategy.
• Mentor and coach statisticians to build capability and quality.

We are looking for professionals with these required skills to achieve our goals:

• Advanced degree in Statistics, Biostatistics or related quantitative discipline (MSc or equivalent) with significant relevant post‑graduate experience, in oncology, within the pharmaceutical industry or a clinical research setting.
• Proven track record contributing statistical expertise to early and/or late phase clinical development.
• Practical experience implementing simulations and statistical methods using R, Python or similar tools.
• Clear written and verbal communication skills for explaining methods and results to non‑statistical colleagues.
• Strong organisation and time management across multiple projects and deadlines

Please note the following skills are not necessary, just preferred, if you do not have them, please still apply:

• PhD in Statistics, Biostatistics, or closely related field.
• Experience with Bayesian methods, adaptive trial designs, and advanced modelling.
• Experience applying statistical methods to disease modelling, high‑dimensional data, or real‑world evidence.
• Experience mentoring or leading small technical teams.
• Experience preparing regulatory documents and interacting with regulators.
• Comfortable working in high‑performance computing or large simulation environments.

Closing Date for Applications 4th March 2026

Please take a copy of the

Job Description , as this will not be available post closure of the advert.
When applying for this role, please use the 'cover letter' of the online application or your CV to describe how you meet the competencies for this role, as outlined in the job requirements above. The information that you have provided in your cover letter and CV will be used to assess your application.

At GSK, we have bold ambitions for patients, aiming to positively impact the health of 2.5 billion people by the end of the decade. Our R&D focuses on discovering and delivering vaccines and medicines, combining our understanding of the immune system with cutting‑edge technology to transform people's lives. GSK fosters a culture ambitious for patients, accountable for impact, and committed to doing the right thing, making sure that we focus our efforts on accelerating significant…